Skip to main content
. 2024 Jan 4;46(1):2294151. doi: 10.1080/0886022X.2023.2294151

Table 1.

Characteristics of the patients.

Variables All (n = 138) Acute kidney injury
p
No (n = 105) Yes (n = 33)
Baseline characteristics        
 Age (years) 65.26 ± 14.84 66.46 ± 14.57 61.45 ± 15.26 .068
 Female, n (%) 55 (39.86) 42 (40.00) 13 (39.39) .951
Comorbidities, n (%)        
 Diabetes 9 (6.52) 5 (4.76) 4 (12.12) .135
 Chronic cardiovascular disease 40 (28.99) 31 (29.52) 9 (27.27) .977
 Mental disorder 14 (10.14) 10 (9.52) 4 (12.12) .666
 Dementia 5 (3.62) 4 (3.81) 1 (3.03) .834
Institution, n (%)       .030
 1 47 (34.0) 40 (38.10) 7 (21.21)  
 2 19 (13.77) 13 (12.38) 6 (18.18)  
 3 22 (15.94) 17 (16.19) 5 (15.15)  
 4 15 (10.87) 14 (13.33) 1 (3.03)  
 5 22 (15.94) 15 (14.29) 7 (21.21)  
 6 13 (9.42) 6 (5.71) 7 (21.21)  
Type of heat stroke, n (%)       .555
 Classic 52 (37.68) 41 (39.05) 11 (33.33)  
 Exertional 86 (62.32) 64 (60.95) 22 (66.67)  
Chief complaints, n (%)        
 Coma 113 (81.88) 82 (78.10) 31 (93.94) .039
 Epileptic seizure 19 (13.77) 12 (11.43) 7 (21.21) .155
Onset time (h) 1.00 (1.00–3.00) 1.50 (1.00–3.00) 1.00 (1.00–3.00) .470
Monitoring parameters at admission        
 Temperature (°C) 40.80 ± 0.81 40.77 ± 0.77 40.89 ± 0.95 .452
 Heart rate (beat/min) 128.57 ± 24.08 124.41 ± 23.64 141.82 ± 20.68 <.001
 Systolic pressure (mmHg) 126.62 ± 31.54 130.30 ± 31.42 114.94 ± 29.44 .014
 Glasgow Coma Scale 8.80 ± 4.19 9.50 ± 4.29 6.58 ± 2.94 <.001
 NEWS 12.51 ± 3.59 11.93 ± 3.69 14.36 ± 2.55 <.001
Body temperature after cooling (°C)        
 Temperature (0.5 h) 39.50 ± 0.99 39.32 ± 0.93 40.01 ± 0.90 <.001
 Temperature (2 h) 37.92 ± 1.00 37.73 ± 0.91 38.49 ± 1.05 <.001
Blood test at admission        
 C-reactive protein (mg/L) 0.62 (0.30–4.40) 0.70 (0.30–5.80) 0.30 (0.30–2.0) .458
 Potassium (mmol/L) 3.64 ± 0.63 3.58 ± 0.60 3.83 ± 0.70 .053
 Sodium (mmol/L) 130.46 ± 13.07 130.86 ± 7.67 129.21 ± 23.19 .529
 Chloride (mmol/L) 97.54 ± 9.06 97.11 ± 8.93 98.89 ± 9.49 .329
 Blood glucose (mmol/L) 11.35 ± 4.87 10.90 ± 4.80 12.70 ± 4.90 .065
 Alanine aminotransferase (IU/L) 23 (16.25–35.00) 22.50 (16.25–35) 23 (17.00–32.58) .620
 Creatinine (mmol/L) 98.11 ± 23.35 93.45 ± 23.26 112.92 ± 16.72 <.001
 Blood urea nitrogen (mmol/L) 6.86 ± 2.73 6.88 ± 2.82 6.80 ± 2.45 .882
 Creatine kinase (U/L) 265.50 (141.80–703.75) 256.00 (133.20–546.55) 395.00(159.50–930.00) .656
 Troponin I (ng/mL) 0.03 (0.01–0.07) 0.02 (0.01–0.06) 0.04 (0.02–0.15) .061
 Prothrombin time (s) 13.25 ± 2.01 13.29 ± 1.90 13.12 ± 2.37 .681
 Lactic acid (mmol/L) 3.42 ± 2.00 3.18 ± 2.08 4.15 ± 1.53 .016
 White blood cell count (1 × 109/L) 10.24 ± 4.71 10.25 ± 4.70 10.23 ± 4.82 .983
 Platelet (1 × 109/L) 197.01 ± 71.15 194.94 ± 69.07 203.55 ± 78.12 .547
Serum chlorine after normal saline infusion (mmol/L) 107.67 ± 6.96 106.30 ± 6.53 110.83 ± 6.99 .008
Volume of normal saline infusion in ED (L) 3.02 ± 1.45 2.82 ± 1.34 3.66 ± 1.61 .006
Total infusion volume (L) 3.69 ± 1.99 3.48 ± 1.82 4.36 ± 2.19 .043
Use of vasoactive drugs, n (%) 28 (20.29) 13 (12.38) 15 (45.45) <.001
Length of stay in ED (h) 10.00 (4.50–19.88) 10.00 (4.50–22.00) 8.00 (4.00–16.50 .160
Outcomes        
 RRT, n (%) 7 (5.07) 2 (1.90) 5 (15.15) .002
 Admitted to ICU, n (%) 52 (37.68) 25 (23.81) 27 (81.82) <.001
 Length of stay in hospital (d) 5.00 (2.00–8.00) 5.00 (0.00–7.00) 7.00 (5.00–12.00) .005
 Length of stay in ICU (d) 0.00 (0.00–4.00) 0.00 (0.00–0.00) 5.00 (3.00–8.00) <.001
 Coagulation impairment, n (%) 20 (14.49) 6 (5.71) 14 (42.42) <.001
 Rhabdomyolysis, n (%) 8 (5.80) 6 (5.71) 2 (6.06) .941
 Mortality, n (%) 10 (7.25) 5 (4.76) 5 (15.15) .045
 Central nervous system damage at discharge, n (%) 16 (11.59) 9 (8.57) 7 (21.21) .048

NEWS: National Early Warning Score; ED: emergency department; ICU: intensive care unit; RRT: renal replacement therapy.